Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose LSD in Healthy Volunteers
NCT05674669Phase 1Completed
- Sponsor
- Eleusis
- Start
- Oct 2015
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lysergide (5 arms), sponsored by Eleusis. Primary endpoints: Assessment of Adverse Events by % frequency at 1 year, AUC 0-24h (pg/mL*h) over time and 2 more. Started Oct 2015; status: completed.
02
Drugs
Lysergide
Beyond the preview
Go deeper on NCT05674669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05674669.